Finance

Lists
RMD:NYSE
Resmed Inc
US$ २३०.०५
+१.४६%
(+३.३२) 1D
अक्टोबर ९, १६:००:०४ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RMD...
Open
US$ २२६.५४
High
US$ २३१.३६
Low
US$ २२६.४२
Mkt. cap
३२.३५ अरब
Avg. vol.
१२.२० लाख
Volume
५४.००
Dividend
१.१५%
Quarterly dividend
US$ ०.६६
Ex-dividend date
२०२६ अगस्ट २०
P/E ratio
२२.०६
52-wk high
US$ २७७.८५
52-wk low
US$ १८०.२६
EPS
US$ १०.४३
Beta
०.७५
Shares outstanding
१४.०६ करोड
No. of employees
११ हजार
Open
US$ २२६.५४
High
US$ २३१.३६
Low
US$ २२६.४२
Mkt. cap
३२.३५ अरब
Avg. vol.
१२.२० लाख
Volume
५४.००
Dividend
१.१५%
Quarterly dividend
US$ ०.६६
Ex-dividend date
२०२६ अगस्ट २०
P/E ratio
२२.०६
52-wk high
US$ २७७.८५
52-wk low
US$ १८०.२६
EPS
US$ १०.४३
Beta
०.७५
Shares outstanding
१४.०६ करोड
No. of employees
११ हजार
News stories
From web sources and news partners
The Motley Fool Australia
The Motley Fool Australia
·
८ घण्टा पहिले
Buy, hold, sell: Resmed, Megaport, ANZ shares
Investing.com Nigeria
Investing.com Nigeria
·
१ दिन पहिले
Form 144 RESMED INC For: 10 October By Investing.com
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed Inc
CEOMichael J. Farrell
Employees११.४ हजार
Foundedजुन १९८९
Headquartersसान डिएगो, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websiteresmed.com
Analyst ratings
Based on 14 analysts giving stock ratings to RMD in the past 3 months
Buy
Buy
5
Hold
9
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for RMD in the last 3 months.
Highest
Current US$ २३०.०५
US$ ३२०.०० (+३९.१०%)
Average
US$ २४२.९१ (+५.५९%)
Lowest
US$ २१३.०० (-७.४१%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Block
Stifel Nicolaus
Hold
Maintained
US$ २३५.००
+२.२%
10/02/2026
Craig Wong-Pan
RBC Capital
Buy
Upgraded
US$ २६२.००
+१३.९%
09/15/2026
Laura Sutcliffe
Citi
Hold
Maintained
US$ २४०.००
+४.३%
09/10/2026
Brett Fishbin
KeyBanc
Buy
Reiterated
US$ २६७.००
+१६.१%
08/31/2026
Jackson Philips
Rothschild & Co Redburn
Hold
Initiated
US$ २३०.००
-०%
08/19/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
US$ २३५.००
+२.२%
08/11/2026
Unknown Analyst
Oppenheimer
Hold
Reiterated
-
-
08/07/2026
Adam Maeder
Piper Sandler
Hold
Maintained
US$ २२५.००
-२.२%
08/07/2026
David Rescott
Robert W. Baird
Hold
Maintained
US$ २१३.००
-७.४%
08/07/2026
Nathan Treybeck
Wells Fargo
Hold
Reiterated
US$ २१५.००
-६.५%
08/07/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
08/07/2026
Michael Matson
Needham
Hold
Maintained
-
-
08/07/2026
Lyanne Harrison
Bank of America Securities
Buy
Maintained
US$ ३२०.००
+३९.१%
07/29/2026
David Bailey
Morgan Stanley
Hold
Maintained
US$ २३०.००
-०%
07/13/2026
Matthew Taylor
Jefferies
Hold
Maintained
US$ २२५.००
-२.२%
07/10/2026
Unknown Analyst
Jefferies
Hold
Reiterated
US$ २२५.००
-२.२%
07/10/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
US$ २२७.००
-१.३%
05/01/2026
Unknown Analyst
J.P. Morgan
Buy
Maintained
-
-
04/15/2026
Chris Cooper
J.P. Morgan
Buy
Initiated
-
-
04/15/2026
Unknown Analyst
Evercore ISI
Buy
Maintained
US$ २५५.००
+१०.८%
04/13/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
US$ २७०.००
+१७.४%
01/30/2026
Mark Wilson CFA
RBC Capital
Buy
Maintained
US$ ३१४.००
+३६.५%
01/30/2026
Last report
२०२६ अगस्ट ६
Fiscal period
Q4 2026
US$ २.९५ / US$ २.८९
+१.९८%beat
Revenue / Est. (USD)
१.४६ अरब / १.४६ अरब
+०.२१%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.३४ अरब
१.४२ अरब
१.४३ अरब
१.४६ अरब
Cost of goods sold
५०.६९ करोड
५३.६३ करोड
५३.२६ करोड
५९.४१ करोड
Cost of revenue
५०.६९ करोड
५३.६३ करोड
५३.२६ करोड
५९.४१ करोड
Research and development expenses
८.७३ करोड
९.१० करोड
९.४३ करोड
१०.५७ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२५.९२ करोड
२७.५७ करोड
२७.९८ करोड
२९.३४ करोड
Operating expense
३६.६३ करोड
३८.६२ करोड
३९.३२ करोड
४१.७९ करोड
Total operating expenses
८७.३२ करोड
९२.२५ करोड
९२.५७ करोड
१.०१ अरब
Operating income
४६.२३ करोड
५०.०३ करोड
५०.५७ करोड
४५.१६ करोड
Other non operating income
-३८.३६ लाख
४२.०० हजार
१.८१ लाख
४४.०२ लाख
EBT including unusual items
४४.६८ करोड
४९.६१ करोड
५०.२३ करोड
४७.४२ करोड
EBT excluding unusual items
४६.८८ करोड
५०.४५ करोड
५१.८३ करोड
४७.६१ करोड
Income tax expense
९.८३ करोड
१०.३६ करोड
१०.३६ करोड
९.०७ करोड
Effective tax rate
२१.९९%
२०.८७%
२०.६२%
१९.१४%
Other operating expenses
-
-
-
-
Net income
३४.८५ करोड
३९.२६ करोड
३९.८७ करोड
३८.३४ करोड
Net profit margin
२६.१०%
२७.५९%
२७.८६%
२६.२०%
Earnings per share
२.५५
२.८१
०.२९
०.३०
Interest and investment income
४६.८६ लाख
४४.५९ लाख
३८.०४ लाख
३.१८ करोड
Interest expense
-
-
-
-
Net interest expenses
४६.८६ लाख
४४.५९ लाख
३८.०४ लाख
३.१८ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
५०.३६ करोड
५४.३८ करोड
५५.८२ करोड
४९.०१ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू